Pre-treatment predictors of attrition in a randomised controlled trial of psychological therapy for severe and enduring anorexia nervosa by Elbaky, Ghada B. Abd. et al.
Abd Elbaky et al. BMC Psychiatry 2014, 14:69
http://www.biomedcentral.com/1471-244X/14/69RESEARCH ARTICLE Open AccessPre-treatment predictors of attrition in a
randomised controlled trial of psychological
therapy for severe and enduring anorexia nervosa
Ghada B Abd Elbaky1†, Phillipa J Hay2,3*†, Daniel le Grange4, Hubert Lacey5, Ross D Crosby6,7* and Stephen Touyz8Abstract
Background: Attrition is common in the treatment of anorexia nervosa and its causes are complex and incompletely
understood. In particular, its relationship with adaptive function and motivational stage of change has been little
studied. This study aimed to (1) investigate and (2) compare the strength of associations between adaptive function,
stage of change and other previously found factors such as illness sub-type and treatment attrition in women with
severe and enduring anorexia nervosa (SE-AN).
Methods: Participants were 63 adult women with SE-AN of at least 7 years duration who were enrolled in a multi-site
randomized controlled trial conducted from July 2007 through June 2011. Treatment comprised 30 outpatient visits
over 8 months of either Cognitive Behaviour Therapy for Anorexia Nervosa (CBT-AN) or Specialist Supportive Clinical
Management (SSCM) both of which were modified for severe and enduring illness. Assessments were done at baseline,
end of treatment, and 6 and 12 month post treatment follow-up. Demographic variables, duration of illness, specific
and generic health related quality of life (QoL), eating disorder (ED) and mood disorder symptoms, social adjustment,
body mass index (BMI), and motivation for change were assessed with interview and self-report questionnaires.
Treatment attrition was defined as leaving therapy after either premature termination according to trial protocol or self-
instigated discharge. Binary logistic regression was used to investigate relative strength of associations.
Results: Those who did not complete treatment were significantly more likely to have the purging sub-type of
anorexia nervosa and poorer ED related QoL. There were no significant differences between attrition and which therapy
was received, educational level, and global ED psychopathology, stage of change, BMI, social adjustment, duration of
illness or level of depression. The strongest predictors on multivariable analysis were ED QoL and AN-purging subtype.
Conclusion: This study supported previous findings of associations between attrition and purging subtype.
Furthermore, we found associations between a potentially important cycle of attrition, and poorer EDQoL, which has
not been previously reported. Contrary to expectations we did not find an association with BMI, severity of ED
symptoms, low level of motivation to change ED features, or level of education.
Keywords: Anorexia nervosa, Attrition, Premature termination of treatment, Eating disorders, Dropout, Treatment* Correspondence: P.hay@uws.edu.au; Rcrosby@nrifargo.com
†Equal contributors
2School of Medicine, Centre for Health Research, University of Western
Sydney, Sydney, Australia
6Neuropsychiatric Research Institute, Fargo, ND, USA
Full list of author information is available at the end of the article
© 2014 Abd Elbaky et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public
Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this
article, unless otherwise stated.
Abd Elbaky et al. BMC Psychiatry 2014, 14:69 Page 2 of 8
http://www.biomedcentral.com/1471-244X/14/69Background
Attrition rates for anorexia nervosa (AN) are typically
high compared to other mental health problems and
other eating disorders, and are between 20.2% to 51% in
inpatient samples and 29% to 73% in outpatient samples
[1]. Furthermore, those who drop out of treatment for
AN have a poor prognosis and an increased likelihood
of rehospitalisation [1]. The causes of treatment non-
completion are complex and incompletely understood. A
critical review by Wallier et al. [2] of inpatient treatment
drop-out in AN found weight on admission, anorexia
nervosa-purging subtype, and the absence of depression
were significantly related to attrition. However, compari-
sons across the seven studies selected in this review were
difficult because of methodological variations in defin-
ition of attrition, sample composition, and the factors
considered potential predictors. A larger and more com-
prehensive review [1] of 26 studies found no evidence
that baseline eating disorder symptom severity, psychi-
atric co-morbidity or treatment issues affected dropout
and concluded that factors associated with dropout were
inconsistent due to methodological flaws and small sam-
ple sizes. The most consistent association was with the
purging subtype of AN. There was also good evidence
that two psychological traits (high maturity fear and im-
pulsivity) and two personality dimensions (low self-
directedness and low cooperativeness) were related to
dropout.
We have since conducted a systematic review [3]
which identified 13 further studies [4-16]. We also con-
cluded that AN-purging subtype, personality traits, eat-
ing disorder features such as desired low body mass
index (BMI), drive for thinness, dietary restriction and
higher weight concerns and psychiatric co-morbidity,
were associated with attrition. However, in two of eight
studies that specifically examined eating disorder symp-
toms there were no associations between such features
and attrition and little was known regarding other puta-
tive predictors of attrition such as motivational stage of
change. This is despite the well-known ambivalence
about treatment and low motivation for recovery in AN
[17] due to at least in part the ego–syntonic quality of
the illness i.e., the sense of accomplishment and moral
virtue people derive from their pursuit of thinness. It has
been argued for example that AN serves a functional
purpose through providing identity and a sense of self-
worth, despite its serious health risks [18]. Thus people
often undertake treatment reluctantly and only in re-
sponse to pleas from family or friends. This is in spite of
poor psychosocial adjustment and health related quality
of life, especially in severe and enduring anorexia ner-
vosa (SE-AN).
In this study we aimed to first investigate associations
between adaptive function (as reflected in health relatedquality of life and social adjustment), stage of change
and other previously found factors such as illness sub-
type and treatment attrition in women with SE-AN. We
hypothesised that, prior to treatment higher levels of eat-
ing disorder symptoms, lower BMI, longer duration of
illness, presence of purging behaviours, higher levels of
depression, poorer social adjustment, lower level of edu-
cation and poorer motivation to change would predict
attrition. Our second aim was to explore the strength of
association between attrition and health related quality
of life, stage of change and other more established pre-
dictors of attrition.
Methods
This study is a secondary analysis of data from a ran-
domized controlled trial conducted at two intervention
sites (i. University of Sydney and ii. St George’s Hos-
pital at the University of London) and a data and co-
ordinating centre (the University of Chicago) [19].
Sixty-three female participants were randomized to
Cognitive Behaviour Therapy for Anorexia Nervosa
(CBT-AN) or Specialist Supportive Clinical Manage-
ment (SSCM). All participants met DSM-IV [20] cri-
teria for AN, excluding criterion D (amenorrhea), for
more than 7 years (thus also meeting DSM-5 criteria
[21]). Participants received 30 50-minute individual treat-
ment sessions provided over a period of eight months in
an outpatient setting.
Participants
Participants were recruited from July 2007 to November
2010 by advertising to clinicians, clinics treating eating
disorders (EDs), and on generic websites. After telephone
screening (n = 159) to determine eligibility, 73 (46%) were
invited for in-person assessment (see Figure 1). Respective
site study coordinators described the protocol in detail to
participants before written informed consent was obtained
and the assessments conducted. Participants were eligible
if they were female (males were excluded as we estimated
that the number of such cases would be negligible), aged
18 years or more, met DSM-IV [20] criteria for AN, ex-
cluding criterion D (amenorrhea), and had an illness dur-
ation of at least 7 years. Participants were excluded from
the study if they presented with a current manic episode
or psychosis, current alcohol or substance abuse or de-
pendence, significant current medical or neurological ill-
ness (including seizure disorder), with the exception of
nutrition-related alterations that impact on weight, were
engaged in psychotherapy and not willing to suspend
treatment for the duration of their participation in the
study, had plans to move beyond commuting distance
from the study site in the following 12 months, or did not
live within commuting distance to the study site. Eighty-
six per cent (n = 63) of eligible participants agreed to
Randomised and started treatment
n=61 (97%)
Randomised but did not start 
treatment n=2 (3%)
Started treatment but did not 
completed to 15 weeks n=6 (9.5%)
Completed 15-29 weeks of
treatment n=7 (11%)
Completed to 15 weeks of
treatment n=55 (87%)
Completed >30 treatment
(32 weeks) n=48 (76%)
Enrolled in trial n=63
Figure 1 Participant flow through treatment #.
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meet DSM weight loss [20,21] or trial illness duration
criteria.
Treatments
Participants were randomly assigned to either CBT-AN or
SSCM by a biostatistician in the Data and Coordinating
Centre at the University of Chicago, independent from
either intervention sites. Randomization was conducted
using Ephron’s biased coin approach, stratified within sites
by subtype of illness (restrictive and binge-purge) and psy-
chiatric medication status. To minimize therapist effect,
three clinical psychologists with prior experience treating
eating disorders in adults acted as therapists for both the
CBT and SSCM conditions. All therapists attended two
2-day in-person workshops for training in the manualised
treatments. All therapists treated pilot cases and were
supervised by senior clinicians throughout the duration of
the trial. Treatment occurred in outpatient settings at the
University of London, and St George’s Hospital, University
of London. Both treatments involved 30 individual treat-
ment sessions provided over eight months.SSCM includes education, care and support, while fos-
tering a therapeutic relationship that promotes adher-
ence to treatment. Supportive psychotherapy aims to
assist the patient through use of praise, reassurance and
advice. The rationale for this emphasis in treatment is
that improvement in domains outside the core pathology
can significantly affect patient well-being and disease
burden, and research suggests that treatments that target
psychosocial functioning are especially appropriate when
there has been repeated relapse or a long duration of ill-
ness. Ultimately, SSCM aims to help individuals to im-
prove their quality of life, which will further motivate
and enable them to make progress on their core ED
pathology.
CBT-AN and SSCM were both modified to prioritize
quality of life and harm minimization associated with
SE-AN, but in both weight gain was an important sec-
ondary aim. The primary outcome measures were se-
lected to assess the extent to which individuals were
better able to find satisfaction in their lives and engage
meaningfully with significant others as a result of treat-
ment. The treatments were distinct in that CBT-AN
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whereas SSCM made use of a more collaborative and
supportive therapeutic style.
Assessment
Participants were assessed at pre-treatment and end of
treatment by independent assessors blind to treatment
assignment. Socio-demographic data were obtained by
interview. Eating disorder features were assessed with
the Eating Disorder Examination [22]. The EDE is a
standardized investigator-based interview that mea-
sures the severity of the characteristic psychopath-
ology of eating disorders. Studies consistently support
its use, sensitivity, reliability and validity, making it
the gold standard for assessing eating disorders. It in-
cludes investigator measurement of weight and height
to calculate BMI (kg/m2).
Motivation to change was assessed with the Anorexia
Nervosa Stages of Change Questionnaire (ANSOCQ)
[23]. The ANSOCQ is a 20-item multiple choice ques-
tionnaire that assesses a patient’s readiness to recover
from AN. It has demonstrated good validity and has
high levels of inter-rater and test–retest reliability.
Eating disorder related quality of life was assessed
with the Eating Disorder Quality of Life questionnaire
(EDQoL) [24]. The EDQoL is a standardized and vali-
dated 25-item instrument assessing quality of life in eating
disorder populations across four subscales: psychological,
physical and cognitive, financial, and work or school. This
is the first instrument designed to assess quality of life in
eating disorder patients. Because of an inherent bias in
existing instruments towards assessing occupational at-
tainment, it is often a challenge to accurately evaluate
quality of life in this population. This instrument is
uniquely designed to assess relevant components of qual-
ity of life for individuals with anorexia nervosa and has
demonstrated reliability and validity.
General health related quality of life was assessed with
the Short Form-12 Health Status Questionnaire (SF-12)
[25]. The well validated SF-12 measures dimensions of
health and role limitations due to physical and mental
health, for which Mental (MCS) and Physical Compo-
nent Summary (PCS) scales can be derived.
Depression was assessed with the Beck Depression In-
ventory (BDI) [26]. The BDI is a 21–question scale with
each answer rated 0–3, this scale is widely used across
the entire spectrum of studies of psychopathology and
psychotherapy.
Social adjustment was assessed with the Weissman So-
cial Adjustment Scale (WSAS) [27] The WSAS assess
social adjustment in multiple areas of functioning, in-
cluding marital, family, work, economic and leisure. The
scale has well established reliability and validity and has
been used in a wide variety of populations.Attrition
Previous reviews e.g. [1,3] have not identified an agreed
definition of treatment completion. Furthermore, the
small sample size of the present study precluded separ-
ate analyses of treatment non-engagement (randomised
but did not engage in treatment), early attrition (in this
study defined as less than 15 weeks of treatment com-
peted, the definition used in the main report of the trial
[19] (p.6) and late attrition (in this study defined as com-
pleting 15–29 weeks of treatment). As shown on Figure 1,
two participants were randomised but failed to engage in
treatment, 55 participants completed at least 15 weeks of
treatment (as reported previously [19]), and 48 partici-
pants completed 30 or more weeks of treatment.
Statistical analyses
Data were analysed using SPSS v 10. Data were inspected
for normality. Univariate analyses were conducted on cat-
egorical data using Chi-square test (with Yates correction
for small cells), and on continuous data using t-test for
parametric data and Mann–Whitney U test for non-
parametric data. The alpha level was corrected for mul-
tiple testing to ≤ 0.01. Binary logistic regression analysis
was used to model the predictors of treatment dropout
that were identified in the univariate analyses, namely dur-
ation of anorexia nervosa, AN-subtype, global EDE score,
EDQoL total and WSAS scores. (Logistic regression was
dictated by the dichotomous outcome. More sophisticated
multivariable analyses, such as structural equation model-
ling, were precluded by the insufficient sample size). The
model was run with forward entry where the best variable
is entered, then the next, etc., until no more variables sig-
nificantly contribute to the prediction. The model was
then run with backward entry whereby all variables are
forced in, and one-by-one non-significant variables are re-
moved. As the final results did not differ, only the forward
entry model is reported in this paper.
Results
A total of 63 participants were randomly assigned to
CBT-AN (n = 31), or SSCM (n = 32). All study partici-
pants were female and ranged in age from 20 to 61
years. As reported in Table 1 participants had severe and
enduring illness (as reflected in the mean global EDE
score of 2.78 and mean duration of illness of 14 years)
and very poor health related quality of life (as reflected
in mean SF-12 mental health component score of 31.88).
Applying DSM-5 [21] definitions of severity based on
BMI, the mean BMI of this sample was in the moder-
ately severe range i.e. between 16 and 16.99.
Rates of treatment completion did not differ by site
(23, 79%, completed treatment in Sydney and 25, 74%, in
London) and this difference was not significant (χ2 =
0.768, df = 1, p = 0.41). Demographic and clinical features
Table 1 Demographic and clinical features of those who completed treatment and those who did not complete treatment
Feature Completers Non completers Total Statistical result
n = 48 n = 15 n = 63
n (%) χ2, df, p
Anorexia Nervosa Purging type 8 (16.6%) 8 (53.3%) 16 (25.4%) 8.11, 1, 0.008*
Graduate education 32 (67%) 8 (57%) 40 (64%) 0.43, 1, 0.36
Randomised to CBT therapy 22 (46%) 9 (60%) 31 (49%) 0.92, 1, 0.34
Mean (SD) t, df, p
EDE global score 2.78 (1.28) 3.70 (1.45) 3.00 (1.37) 2.34, 61, 0.01
EDE restraint score 2.86 (1.81) 3.90 (1.27) 3.11 (1.75) 2.05, 61, 0.023
EDE eating concern score 2.62 (1.49) 3.28 (1.54) 2.78 (1.52) 1.49, 61, 0.07
EDE shape concern score 3.08 (1.36) 4.04 (1.71) 3.31 (1.50) 2.23, 61, 0.015
EDE weight concern score 2.56 (1.62) 3.57 (1.96) 2.80 (1.75) 2.01, 61, 0.024
SF 12 physical health component score 48.55 (9.70) 50.29 (6.75) 48.99 (9.03) 0.87, 61, 0.19
SF 12 mental health component score 33.39 (12.55) 27.44 (10.20) 31.88 (12.20) −1.49, 61, 0.07
BDI total Score 25.04 (14.10) 30.44 (12.59) 26.41 (13.84) 1.20, 61, 0.12
EDQOL psychological score 2.53 (0.75) 3.08 (0.67) 2.66 (0.77) 2.53, 61, 0.007*
EDQOL physiological cognitive score 2.09 (0.88) 2.31 (0.31) 2.14 (0.78) 0.88, 61, 0.19
EDQoL Work & school score 0.61 (0.68) 1.29 (0.65) 0.78 (0.73) 3,18, 52, 0.002*
EDQoL Financial score 0.48 (0.69) 1.14 (0.71) 0.63 (0.74) 3.12, 61, 0.002*
EDQoL Total score 1.67 (0.60) 2.21 (0.38) 1.81 (0.60) 3.06, 61, 0.002*
Work and Social Adjustment Scale Total score 16.98 (10.36) 22.69 (8.05) 18.43 (10.08) 1.94, 61, 0.029
ANSOQ Total score 2.59 (0.58) 2.48 (0.63) 2.56 (0.59) 0.89, 61, 0.18
ANSOCQ Weight gain score 2.19 (0.73) 1.98 (0.79) 2.14 (0.74) 1.11, 61, 0.14
ANSOCQ Eating, Weight and Shape score 2.82 (0.66) 2.77 (0.58) 2.81 (0.64) .44, 61, 0.32
ANSOCQ Ego –Alien Aspects score 2.79 (0.69) 2.72 (0.77) 2.77 (0.71) .591, 61, 0.27
Median (IQ range) Mann–Whitney UZ, p
Duration of illness/years 14 (9–19.8) 19 (14–26) 14 (9–23) 1.74, 0.041
Probability levels are one-tailed, *p < 0.01, CBT = Cognitive Behaviour Therapy, EDE = Eating Disorder Examination [22], SF = Short-Form [25], BDI = Beck depression
inventory [26], EDQoL = Eating Disorder Quality of Life [24], ANSOCQ = Anorexia Nervosa Stage of Change Questionnaire [23].
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and did not complete treatment are found in Table 1.
There were no differences between the two therapy
groups and treatment completion. Those who did not
complete treatment were significantly more likely to be
of AN-purging subtype and to have poorer EDQoL.
There were no significant differences between attrition
and which psychological therapy was received, educa-
tional level, motivational stage of change, BMI, global
eating disorder psychopathology. general health related
quality of life, social adjustment, duration of anorexia
nervosa or level of depression.
The results of the logistic regression are found in
Table 2. With forward entry the variables EDQoL total
score (OR = 0.197 95% CI 0.047; 0.832, p = 0.027) and
AN-subtype (OR = 0.259, 95% CI 0.067; 1.009, p = 0.051)
were retained in the model. However, the OR CI forAN-subtype included 1.0 and just failed to reach
significance.
Discussion
This study aimed to first to investigate associations be-
tween health related quality of life, stage of change and
other previously found factors such as illness sub-type
and treatment attrition in women with SE-AN, and the
second aim was to explore the strength of association
between adaptive function and stage of change and other
more established predictors of attrition. In this study, as
in Halmi et al. [28] there were few factors associated
with treatment dropout; one of which was however not
previously reported namely, poor eating disorder quality
of life. The previously consistently identified factor of
AN-purging subtype [1-3] was as well associated with
treatment attrition in this study. There were no significant
Table 2 Results of multivariable (logistic regression forward) analyses with treatment completion as dependent variable
Predictor (independent) variable Nagelkerke R2 Odds ratio 95% C.I. p (variable) p (overall model)
Step 1: 0.216 0.144 0.035; 0.603 0.008 0.002
ED Quality of Life Total score [24]
Step 2:
ED Quality of Life Total score [24] 0.292 0.197 0.047; 0.832 0.027 0.001
AN-purging subtype - 0.259 0.067; 1.009 0.051
Note: Variables not in the final equation were duration of illness (p = 0.13), global Eating Disorder Examination [22] (p = 0.58) and Weissman Social Adjustment
Scale scores [27] (p = 0.33).
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educational level, motivational stage of change, BMI, glo-
bal eating disorder psychopathology, general health related
quality of life, social adjustment, duration of illness or level
of depression. Furthermore, the strongest predictors on
multivariable analysis were eating disorder quality of life
and AN-purging subtype.
Our findings are consistent with many others that
have reported AN-purging subtype to predict treatment
attrition [1,2] in both inpatients and outpatient setting.
We similarly found the EDE global and subscale scores
to be associated with higher a level of attrition which
supports the majority of previous studies. Thus, the
more severely ill participants, in terms of behavioural,
social and psychological parameters, the more likely they
are to drop out of treatment, and this was unaffected by
the specific psychological therapy they received. Clini-
cians should take particular effort to engage and retain
these patients in care, as they have more severe illness
and whilst in most need of care are more likely to ter-
minate prematurely.
To our knowledge, this is the first study to find that
overall eating disorder specific quality of life predicted
attrition. In addition overall specific quality of life was
the strongest predictor in the multivariable model in this
study. As persistent anorexia nervosa most often over
time is associated with an increase in social and inter-
personal deficits eating disorder quality of life may be an
even stronger predictor in studies where there is more
variability in illness duration and adaptive function. Our
findings highlight the importance of further investigation
of the relationship between this and attrition, and inter-
ventions to prevent and/or break a cycle of functional
decline and premature termination of treatment. The
generic measure of quality of life and eating disorder
specific quality of life in the physical and cognitive do-
mains (as compared to financial, psychological, work
and schooling) did not however predict attrition. This
may be because the ego-syntonic nature of anorexia ner-
vosa is associated with denial or minimisation of the
physical and cognitive effects of illness.
Whilst depression was associated with higher level of at-
trition this was not statistically significant, and depressionhas not consistently been associated with attrition in other
studies. For example, Masson et al. [29] reported that co-
morbidity with depression in fact enhanced treatment
completion in the inpatient setting. However, it is possible
the study lacked statistical power to detect a difference.
This may also apply to the findings for global eating dis-
order psychopathology, social adjustment and duration of
illness where there appeared to be associations that how-
ever failed to reach significance. Caution should thus be
applied to these negative findings. The lack of statistical
association between preadmission BMI and premature
treatment termination that we found may have been be-
cause this was an outpatient trial and BMI was not as low
or as variable as BMI as in other studies. However, most
other studies have also not found an association with BMI
and attrition.
Our findings did not support those of Dalle Grave
et al. [30] and Huas et al. [12] who found an association
between level of education and attrition. This may have
been because of the relatively high level of graduate edu-
cation (67%) and low level of variability in education
level in the present study participants.
Findings continue to be inconsistent with regard to
the few studies investigating level of motivation and
treatment attrition. In our study we did not confirm our
hypothesis that stage of change would predict treatment
attrition. This may have been because the motivation to
participate in this study was for the stated primary aim
of improved quality of life rather than weight gain (al-
though weight gain was clearly an important secondary
aim). However, the ANSOCQ questionnaire measures
motivation related to reduction in eating disorder behav-
iours and increase in body weight, not change in quality
of life. The relationship between stage of change and
various measure of treatment outcome is also very com-
plex. For example, whilst finding no relationship be-
tween stage of change and BMI outcome, Mander at al.
[31] found being at the stage of contemplation predicted
treatment alliance.
The strengths of this study are the comprehensive
range of predictors and validated assessment instruments.
The major limitations are the small sample and unequal
groups (n = 15 non completers vs. 48 completers) which
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cluded separate analyses of participants with early and
later attrition and examination of bidrectionality of rela-
tionships using more sophisticated analytic methods such
as structural equation modelling. Unequal group sizes and
small numbers in the attrition arm were the results of the
low rates of dropout in the present study. This contrasts
with other outpatient studies, where completion rates can
be as low as 27% [1]. A more recent outpatient trial of
Zipfel et al. [32] also reported a treatment completion rate
of 74% but Schmidt et al. [33] reported that only 25% par-
ticipants completed the majority (>61%) of sessions. The
low rates in the present may have been because of the
modification of treatment goals and tailoring of treatment
to the participant’s stage of change. Finally, co-morbidity
more broadly, i.e. personality characteristics, could not be
examined in the present study. The findings as well may
not generalise to participants with shorter illness duration.
Conclusion
As expected, AN-purging subtype was associated with a
higher treatment attrition rate. A new finding was the
association with eating disorder specific overall quality
of life. However, particularly given this study’s small
sample size, further study is needed to investigate the
likely bidirectional nature of declining adaptive function
and increase risk of treatment dropout in this serious ill-
ness. More research is needed to test our supposition
that people with long standing anorexia nervosa may be
more motivated to engage in treatment where goals are
modified from primacy of weight regain to improved
quality of life. Potentially therapy should be also further
modified to address the needs of those with greater defi-
cits in adaptive function.
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